Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora Populations
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01316783|
Recruitment Status : Enrolling by invitation
First Posted : March 16, 2011
Last Update Posted : May 18, 2018
- African Americans have one of the highest rates of type 2 diabetes in the United States, and often have other medical problems related to obesity and cardiovascular disease. These conditions have various risk factors, including high blood sugar levels, high cholesterol levels, and insulin resistance. However, these risk factors have not been studied very closely in individuals with African ancestry, including Afro-Caribbean and sub-Saharan Africa migrant populations. Researchers are interested in conducting a genetic study on obesity, adult-onset diabetes, heart disease, and other common health conditions in individuals with African ancestry.
- To collect genetic and non-genetic information from individuals with African ancestry to study common health conditions related to obesity, adult-onset diabetes, and heart disease.
- Individuals at least 18 years of age who self-identify as African American, Afro-Caribbean, or migrants from sub Saharan Africa.
- Participants will undergo a physical examination and will provide a blood sample for study.
- Participants will also answer questions about personal and family medical history and current lifestyle behaviors.
- No treatment will be provided as part of this protocol.
|Condition or disease|
|Diabetes Cardiovascular Disease|
|Study Type :||Observational|
|Actual Enrollment :||416 participants|
|Official Title:||Genetics of Obesity, Diabetes, and Heart Disease in African Diaspora Populations|
|Study Start Date :||March 15, 2011|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01316783
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Charles N Rotimi, M.D.||National Human Genome Research Institute (NHGRI)|